BIIB vs FRSH · P/E 21, rev $9.89B vs P/E 16, rev $466.0M
Biogen Inc (BIIB) versus Freshworks Inc (FRSH) — a side-by-side from cached financials, not a winner call.
Biogen Inc (BIIB) is a drug manufacturers - general company listed on NASDAQ. It is led by Christopher A. Viehbacher.
Freshworks Inc (FRSH) is a software - application company listed on US.
Latest reported BIIB revenue for 2025-12-31 was $9.89B. Net income was $1.29B. Revenue was up 2.2% from 2024-12-31 to 2025-12-31. BIIB currently screens at market cap $29.33B and trailing P/E 21.4.
Latest reported FRSH revenue for 2026-06-30 was $466.0M. Net income was -$1.6M. FRSH currently screens at market cap $2.62B and trailing P/E 15.5.
BIIB currently screens at market cap $29.33B and trailing P/E 21.4. FRSH currently screens at market cap $2.62B and trailing P/E 15.5.
Not investment advice. Open the BIIB and FRSH stock pages for the full models.
Not investment advice.